Clinical Trials / Research
A key component of the Women's Cancer Center at Stanford is translational research, where laboratory discoveries are shepherded into the clinic, improving prevention efforts, early diagnosis and treatment, and patient outcomes. Other researchers are focused on areas such as molecular classification of tumors, improved imaging and gene sequencing methods.
Some of our translations research efforts include:
- Stem cell research that may influence new treatments
- Early detection of ovarian cancer using biomarkers and new methods of imaging
- Understanding drug resistance in certain ovarian cancers
- New ways of classifying ovarian cancer; development of vaccines to prevent relapse
- Use of novel chemotherapeutics in uterine tumors
- Mechanisms of HPV-induced malignancy, and new prevention and detection strategies for cervical cancer
- Clinical trials studying novel chemotherapeutic agents, prophylactic chemotherapy, biologic agents, angiogenesis inhibitors, vaccines and antibody therapies
See a complete list of clinical trials
Trial Administration